These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32795664)

  • 1. Role of B cells in immune-mediated dermatoses.
    Wang WM; Guo L; Jin HZ
    Mol Immunol; 2020 Oct; 126():95-100. PubMed ID: 32795664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous neutralizing anti-IL-1 alpha autoantibodies in inflammatory skin diseases: possible natural inhibitor for over expressed epidermal IL-1.
    Mizutani H; Ohmoto Y; Kupper TS; Shimizu M
    J Dermatol Sci; 1998 May; 20(1):63-71. PubMed ID: 10342749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
    Chen A; Yoshizaki A; Miyagaki T; Streilein RD; Tedder TF; Hall RP
    J Invest Dermatol; 2021 Feb; 141(2):443-446. PubMed ID: 32628952
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.
    Antiga E; Quaglino P; Volpi W; Pierini I; Del Bianco E; Bianchi B; Novelli M; Savoia P; Bernengo MG; Fabbri P; Caproni M
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):222-30. PubMed ID: 23331964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid.
    Kabuto M; Fujimoto N; Takahashi T; Tanaka T
    Br J Dermatol; 2017 May; 176(5):1204-1212. PubMed ID: 27716906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus foliaceus progressing to bullous pemphigoid.
    Iwakura R; Oiso N; Tateishi C; Suzuki M; Uchida S; Yanagihara S; Hashimoto T; Tsuruta D; Kawada A
    J Dermatol; 2019 Nov; 46(11):e424-e426. PubMed ID: 31342555
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune bullous dermatoses: a review.
    Patrício P; Ferreira C; Gomes MM; Filipe P
    Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses.
    Terras S; Gambichler T; Moritz RK; Altmeyer P; Lambert J
    Int J Dermatol; 2014 Mar; 53(3):294-9. PubMed ID: 23968190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the understanding and treatment of pemphigus and pemphigoid.
    Yamagami J
    F1000Res; 2018; 7():. PubMed ID: 30228865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-Homing Regulatory B Cells Required for Suppression of Cutaneous Inflammation.
    Aira LE; Debes GF
    J Invest Dermatol; 2021 Aug; 141(8):1995-2005.e6. PubMed ID: 33577766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of T cells in pemphigus vulgaris and bullous pemphigoid.
    Fang H; Li Q; Wang G
    Autoimmun Rev; 2020 Nov; 19(11):102661. PubMed ID: 32942041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
    Hammers CM; Stanley JR
    Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity.
    D'Auria L; Bonifati C; Cordiali-Fei P; Leone G; Picardo M; Pietravalle M; Giacalone B; Ameglio F
    Arch Dermatol Res; 1999 Jun; 291(6):354-6. PubMed ID: 10421062
    [No Abstract]   [Full Text] [Related]  

  • 14. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
    Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
    Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10-Producing Regulatory B Cells Are Decreased in Patients with Atopic Dermatitis.
    Yoshihara Y; Ishiuji Y; Yoshizaki A; Kurita M; Hayashi M; Ishiji T; Nakagawa H; Asahina A; Yanaba K
    J Invest Dermatol; 2019 Feb; 139(2):475-478. PubMed ID: 30236612
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
    Dainichi T; Chow Z; Kabashima K
    J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous diseases.
    Economidou J; Avgerinou G; Tsiroyianni A; Stavropoulos P; Vareltzidis A; Katsambas A
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):184-5. PubMed ID: 9784051
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis.
    de la Torre B; Fransson J; Scheynius A
    Clin Exp Rheumatol; 1995; 13(3):345-8. PubMed ID: 7554562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus.
    Zhu HQ; Xu RC; Chen YY; Yuan HJ; Cao H; Zhao XQ; Zheng J; Wang Y; Pan M
    Br J Dermatol; 2015 Jan; 172(1):101-10. PubMed ID: 24935080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
    Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
    J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.